Rhett Brown is a Managing Director and Research Analyst covering the healthcare sector. He began working in the investment field in 1996. Prior to joining Lazard in 2005, he was a research analyst covering healthcare companies at Deutsche Bank Securities and Volpe Brown Whelan & Company. Before entering the investment business, Rhett held various functional roles including basic research, marketing, and sales within the biopharmaceutical industry, working for Amersham Life Science (now GE Healthcare), the Applied Biosystems Division of Perkin Elmer (now owned by Thermo Fisher Scientific), and Immulogic Pharmaceutical Corporation. He has an MBA (Hons) in Finance from the Wharton School, University of Pennsylvania and a BS (Hons) in Biological Sciences from Stanford University. Rhett is a CFA® charterholder.
